This study redesigned the AZ67 allosteric scaffold to prioritise computational leads for anticancer metabolic drug discovery and selected the least variable ligand trajectory among the derivatives and an MM/GBSA profile near -65 kcal/mol versus approximately -40 kcal/mol for AZ67.
PFKFB3 is a druggable regulator of fructose-2,6-bisphosphate production, glycolytic flux, angiogenic metabolism, and tumour-cell survival signalling. This study redesigned the AZ67 allosteric scaffold to prioritise computational leads for anticancer metabolic drug discovery. ChemoDOTS enumeration produced 575,760 virtu...
A. Mohammed, Jameelah K. T. Al-Isawi, M. K. Abd· Journal of Cancer Research U...· 0 citations
Cyclin-dependent kinase 6 (CDK6) contributes to G1-to-S cell-cycle progression and represents an established therapeutic target in hormone receptor-positive breast cancer. However, adverse effects and acquired resistance associated with current CDK4/6 inhibitors support continued investigation of alternative chemical s...
Syarifuddin Husain, Ruzianisra Mohamed, Khairul Bariyyah Abd. Halim et al.· Journal of Molecular Graphic...· 0 citations
Findings validate the diphenylpyrazine scaffold as a promising chemotype for Skp2–Cks1 inhibition and identify C3 as a strong lead for further optimization.
Emadeldin M. Kamel, A. A. Allam, H. Rudayni et al.· Journal of Computer-Aided Mo...· 0 citations
A cost-effective computational workflow for prioritizing ENR inhibitors is demonstrated, providing a foundation for the development of novel antimalarial agents and highlighting Cd3 and Cd5 as the most promising candidates for further development.
Abozur Mohamed Mohyeldin Khalil, Carlos Eliel Maya-Ramírez, A. A. Razzak Mahmood et al.· In Silico Pharmacology· 0 citations
Computational findings support the prioritization of X14 for further experimental validation in glioblastoma therapy, and generally favorable ADMET profiles were observed, hepatotoxicity alerts were predicted for all compounds, which represents an important limitation supporting the prioritization of X14.
Youssef Briach, M. Er-rajy, Jamal Elkhabchi et al.· Biointerface Research in App...· 0 citations
Seven para-substituted flavonoid hybrids against the main protease (Mpro) are designed and M6 is prioritized as a computational lead requiring Mpro inhibition, antiviral, and cytotoxicity validation.
Jawaher H. Alqahtani, Mohammed Ouachekradi, Bahia Abdelfattah et al.· Current Issues in Molecular...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.